|
| [April 19, 2010] |
 |
JDRF Honors Terry and Louise Gregg with 2010 Angel Award
SAN DIEGO --(Business Wire)--
DexCom, Inc. (NASDAQ:DXCM) today announced that The Greater Los Angeles
Chapter of the Juvenile Diabetes Research Foundation (JDRF) will
bestow one of its highest honors, the 2010 Angel Award, to Terry and
Louise Gregg. The Greggs have long been active supporters and personal
contributors to diabetes research. The Greggs will receive the award at
the JDRF's annual fundraiser gala on May 6, 2010 at the Beverly Hilton
Hotel. Past honorees include First Lady Nancy Reagan, award winning
singer/songwriter Garth Brooks, champion boxer Sugar Ray Leonard,
pediatric endocrinologist Francine Kaufman, and philanthropist Barbara
Davis.
"The leadership, passion and commitment that Terry and Louise have shown
in the fight against diabetes have been uniquely incredible. They have
made a real impact that few others have done," said Steve Edelman,
Professor of Medicine in the Division of Endocrinology, Diabetes &
Metabolism at the University of California, San Diego and founder and
director of Taking Control of Your Diabetes. "Louise and I are honored
by this recognition and we will continue to work with those that are
motivated to making a difference in the diabetesworld until a cure is
found," said Gregg.
Terrance H. Gregg is President and CEO of DexCom, Inc. He is also
currently a Special Venture Partner with Galen Partners, a private
equity firm specializing in the healthcare industry. Additionally Mr.
Gregg sits on the board of directors of "Taking Control of Your
Diabetes," a non-profit educational program. In 2002 he retired as
President of Medtronic MiniMed, a world leader in diabetes management
systems. He became President and Chief Operating Officer of MiniMed,
Inc. in 1996 and was instrumental in Medtronic's $3.4 billion
acquisition of MiniMed in 2001. Mr. Gregg served as the 2003-2004 Chair
of the Research Foundation Board of the American Diabetes Association,
and in 2003, Mr. Gregg and his wife were recognized by the American
Diabetes Association with an award for Outstanding Service in Diabetes
Research Funding.
Since its founding in 1970 by parents of children with Type 1 diabetes,
JDRF has awarded more than $1.3 billion to diabetes research grants. The
Los Angeles Chapter contributes roughly $4 million annually to diabetes
research.
About DexCom, Inc.
DexCom, Inc., headquartered in San Diego, California, is developing and
marketing continuous glucose monitoring systems for ambulatory use by
patients with diabetes and by healthcare providers in the hospital.
Cautionary Statement Regarding Forward Looking Statements
DexCom is a medical device company with a limited operating history.
Successful commercialization and sale of the company's products is
subject to numerous risks and uncertainties, including product
performance, a lack of acceptance in the marketplace by physicians and
patients, the company's inability to manufacture products in commercial
quantities at an acceptable cost and quality level, possible delays in
the company's development programs, the inability of patients to receive
reimbursement from third-party payors and inadequate financial and other
resources. Certain of these risks and uncertainties, in addition to
other risks, are more fully described in the company's annual report on
Form 10-K for the period ending December 31, 2009, as filed with the
Securities and Exchange Commission on March 9, 2010.
[ Back To HealthTechZone.com's Homepage ]
|